Apogee Therapeutics, Inc.
APGE
42 insider filings · Latest: Sep 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Aug 8 12:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $134.17 | $737.9K | 168,498(D) | View → |
| Jul 8, 2026 | Jul 11 12:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $133.63 | $2.7M | 995,987(D) | View → |
| Jul 1, 2026 | Jul 3 12:13 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $132.74 | $730.1K | 177,873(D) | View → |
| Jul 1, 2026 | Jul 1 9:00 PM | CARL DAMBKOWSKI | Proposed Sale | 16,500 | $132.73 | $2.2M | — | View → |
| Jun 22, 2026 | Jun 25 12:01 AM | Carl DambkowskiChief Medical Officer | Sale | 26,400 | $132.60 | $3.5M | 179,248(D) | View → |
| Jun 22, 2026 | Jun 25 12:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 80,000 | $132.54 | $10.6M | 1,015,987(D) | View → |
| Jun 22, 2026 | Jun 22 8:48 PM | CARL DAMBKOWSKI | Proposed Sale | 15,400 | $90.38 | $1.4M | — | View → |
| Jun 22, 2026 | Jun 22 2:40 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 80,000 | $132.54 | $10.6M | — | View → |
| Jun 10, 2026 | Jun 12 9:05 PM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $83.38 | $1.7M | 1,095,987(D) | View → |
| Jun 3, 2026 | Jun 6 12:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $78.71 | $432.9K | 205,648(D) | View → |
| May 13, 2026 | May 16 12:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $82.09 | $1.6M | 1,115,987(D) | View → |
| May 13, 2026 | May 13 2:34 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 60,000 | $82.47 | $4.9M | — | View → |
| May 6, 2026 | May 9 12:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $84.14 | $462.8K | 207,023(D) | View → |
| May 6, 2026 | May 6 8:25 PM | CARL DAMBKOWSKI | Proposed Sale | 22,000 | $83.29 | $1.8M | — | View → |
| May 1, 2026 | May 5 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $82.04 | $164.1K | 173,371(D) | View → |
| May 1, 2026 | May 1 8:45 PM | JANE HENDERSON | Proposed Sale | 2,000 | $82.89 | $165.8K | — | View → |
| Apr 16, 2026 | Apr 18 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $90.00 | $180.0K | 175,371(D) | View → |
| Apr 8, 2026 | Apr 11 12:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $82.58 | $1.7M | 1,132,987(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $84.84 | $466.6K | 208,398(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $85.01 | $170.0K | 177,371(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 20 8:05 PM | Michael Thomas HendersonDirector, Chief Executive Officer | Option Exercise | 3,000 | $22.86 | 387,012(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 127,165(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 131,290(D) | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 135,415(D) | View → |
← Previous
Page 2 of 2